Metraipolis › archive › dc_ff0febb4ef04

Mechanism of Bispecific Antibodies and Clinical Research Advances in Lung Cancer — Europe PMC PMID:40511831

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/40511831
DOI: 10.2174/0115680096353819250127065001
License (as archived): solo-consultazione
Archived: 2026-11-07T05:52:02.740Z
SHA-256 of the archived text: 1d6846668d240dc433b33c076dd18c599b60ff4a15dafaa70792267a0d3b75a8
Stable URL of this page: https://metraipolis.com/documento/dc_ff0febb4ef04

How to cite

Mechanism of Bispecific Antibodies and Clinical Research Advances in Lung Cancer — Europe PMC PMID:40511831 — Europe PMC (en), https://europepmc.org/article/MED/40511831 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ff0febb4ef04 (Metraipolis archive dc_ff0febb4ef04, sha256 1d6846668d240dc433b33c076dd18c599b60ff4a15dafaa70792267a0d3b75a8)

BibTeX

@misc{dcff0febb4ef04,
  title = {Mechanism of Bispecific Antibodies and Clinical Research Advances in Lung Cancer — Europe PMC PMID:40511831},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40511831},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ff0febb4ef04; sha256 1d6846668d240dc433b33c076dd18c599b60ff4a15dafaa70792267a0d3b75a8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40511831. Agents can read the archived copy with the MCP tool read_document.